Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

NovaBay Pharmaceuticals (NBY) Long-Term Debt Issuances (2019)

NovaBay Pharmaceuticals (NBY) has disclosed Long-Term Debt Issuances for 6 consecutive years, with $2.0 million as the latest value for Q1 2019.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $2.0 million in Q1 2019 year-over-year; TTM through Dec 2019 was $2.0 million, a N/A change, with the full-year FY2024 number at $500000.0, changed N/A from a year prior.
  • Long-Term Debt Issuances was $2.0 million for Q1 2019 at NovaBay Pharmaceuticals, up from $1.4 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $2.0 million in Q1 2019 to a low of $1.4 million in Q1 2016.